Page last updated: 2024-10-28

hexamethonium and Anxiety

hexamethonium has been researched along with Anxiety in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"In the present study, the effect of alpha-adrenoceptor agents on response to nicotine in an anxiety model (elevated plus-maze) in mice was investigated."3.70Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. ( Babaie, A; Etminani, A; Gharib, B; Homayoun, H; Zarrindast, MR, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roni, MA1
Rahman, S1
Zarrindast, MR1
Homayoun, H1
Babaie, A1
Etminani, A1
Gharib, B1

Other Studies

2 other studies available for hexamethonium and Anxiety

ArticleYear
Neuronal nicotinic receptor antagonist reduces anxiety-like behavior in mice.
    Neuroscience letters, 2011, Oct-31, Volume: 504, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Blood-Brain Barrier; Brain; Exploratory Behavior; Hexamethoni

2011
Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice.
    European journal of pharmacology, 2000, Oct-27, Volume: 407, Issue:1-2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Anxiety; Atropine; Clonidine; Hexa

2000